Functional improvement of mutant keratin cells on addition of desmin: an alternative approach to gene therapy for dominant diseases
Open Access
- 24 June 2004
- journal article
- research article
- Published by Springer Science and Business Media LLC in Gene Therapy
- Vol. 11 (16), 1290-1295
- https://doi.org/10.1038/sj.gt.3302301
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Phenotypes, genotypes and their contribution to understanding keratin functionTrends in Genetics, 2003
- The Epidermis as a Bioreactor: Topically Regulated Cutaneous Delivery into the CirculationHuman Gene Therapy, 2002
- Cutaneous gene transfer and therapy: the present and the futureThe Journal of Gene Medicine, 2001
- Regulated Cutaneous Gene Delivery: The Skin as a BioreactorHuman Gene Therapy, 2000
- Inherited epidermolysis bullosa comes into the new millenium: A revised classification system based on current knowledge of pathogenetic mechanisms and the clinical, laboratory, and epidemiologic findings of large, well-defined patient cohortsJournal of the American Academy of Dermatology, 2000
- Localized in vivo genotypic and phenotypic correction of the albino mutation in skin by RNA-DNA oligonucleotideNature Biotechnology, 2000
- Disease severity correlates with position of keratin point mutations in patients with epidermolysis bullosa simplex.Proceedings of the National Academy of Sciences of the United States of America, 1993
- A mutation in the conserved helix termination peptide of keratin 5 in hereditary skin blisteringNature, 1992
- Epidermolysis Bullosa Simplex: Evidence in Two Families for Keratin Gene AbnormalitiesScience, 1991
- Point mutations in human keratin 14 genes of epidermolysis bullosa simplex patients: Genetic and functional analysesCell, 1991